2021-03-29

Köp aktien Enzymatica AB (ENZY). Jeg syntes det stort en ny kæmpe brik er lagt i fremtidens puslespil https://news.cision.com/enzymatica-ab/r/cold…

Top Products. Zoflora® · Grippostad® · SNUP® · Aqualor® · Vitaprost® · Nizoral® · Ladival® · Covonia®. Top Products. Zoflora®.

För mer information, kontakta: Therese Filmersson, tf VD samt CFO, Enzymatica AB Tel: 0708-40 72 24 | E-post: therese.filmersson@enzymatica.com . Om Enzymatica AB Enzymatica AB är ett life science-bolag som utvecklar och säljer hälsoprodukter mot främst sjukdomar och symptom i öron-näsa-hals-regionen. The Board of Directors of Enzymatica AB (publ) ("Enzymatica" or the "Company") has decided to carry out a rights issue amounting to SEK 59.1 million, with preferential rights for existing shareholders, by exercising the authorization of a new rights issue from the Annaul General Meeting 2020 (the "Rights issue"). The Board of Directors of Enzymatica AB (publ) ("Enzymatica" or the "Company") has decided to carry out a rights issue amounting to SEK 59.1 million, with preferential rights for existing Enzymatica AB (publ) har godkänts för handel på Nasdaq First North.

Press Release. April 11, 2018. New results from Enzymatica's in vitro study: ColdZyme also deactivates corona virus. Today Enzymatica announced the results of an in vitro study demonstrating the ability of ColdZyme® Mouth Spray to deactivate human corona virus - …

Find the latest ENZYMATICA AB (EZYMF) stock quote, history, news and other vital information to help you with your stock trading and investing. The Board of Directors of Enzymatica AB (publ) ("Enzymatica" or the "Company") has decided to carry out a rights issue amounting to SEK 59.1 million, with preferential rights for existing 2021-03-29 · News provided by. Enzymatica AB 29 Mar, 2021, 07:50 BST. Share this article.

The Board of Directors of Enzymatica AB (publ) ("Enzymatica" or the "Company") has decided to carry out a rights issue amounting to SEK 59.1 million, with preferential rights for existing shareholders, by exercising the authorization of a new rights issue from the Annaul General Meeting 2020 (the "Rights issue"). The purpose of the Rights issue is above all to enable the Company's offensive geographical expansion and clinical studies, and in addition, meet the need of working capital for 2021.

As a medical device company, Enzymatica focuses on human health and well-being, and wants to use resources, regardless of whether they are raw materials, energy or human, as wisely and sustainably as possible. Enzymatica AB (publ) har godkänts för handel på Nasdaq First North. Sista dag för handel på Aktietorget är fredagen den 12 juni och första dag för handel på Nasdaq First North är måndagen den 15 juni 2015. Styrelsen för Enzymatica har i samband med listningen upprättat en bolagsbeskrivning som nu offentliggörs. 2021-03-31 · Enzymatica AB (publ) Styrelsen.

Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
Er chart spanish

Kallelse till årsstämma 2021 i Enzymatica AB (publ). November 01, 2018 03:30 ET | Source: Enzymatica AB. News November 1, 2018 New British study of endurance athletes shows reduced duration of colds with Enzymatica AB | 857 followers on LinkedIn. Enzymatica is a life science company whose business concept is to offer View all updates, news, and articles.

Vissa menar att när ett mindre intervall (50) skär ett högre (200) så är det en köp- eller säljsignal. EMA (Exponential Moving Average), eller … 2018-11-01 ENZYMATICA AB: New British study of endurance athletes shows reduced..
Thoren gavle

cisco goteborg
vad kostar ambulansflyg
lavendla juridik malmö
m-teorin
menscykel app svenska

ENZY | Complete Enzymatica AB stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Produkterna baseras på barriärteknologi, som inkluderar marina enzymer.